“Tell me what you eat and I will tell you who you are”—this well-known saying accurately describes the new MEDI method for decoding dietary habits from DNA fragments that was developed at Med Uni Graz in cooperation with an international research team.
FDA converts accelerated to full approval for Padcev-Keytruda combo in bladder cancer
The FDA on Friday granted full approval to Seagen and Astellas Pharma’s Padcev (enfortumab vedotin-ejfv) in combo with Merck’s Keytruda (pembrolizumab) for patients with locally